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Abstract
Purpose To relate erythrocyte sedimentation rates (ESR) and C-reactive protein (CRP) values to different uveitis entisties.
Methods A retrospective study of patients with a first episode of active uveitis visiting the Erasmus University Medical Center,
uveitis clinic, Rotterdam, the Netherlands, was performed. Levels of ESR and CRP were determined within 2 weeks and 1 week
after onset of uveitis, respectively. Uveitis had to be of unknown origin at that moment. The specific etiologic groups were related
to ESR and CRP values.
Results Themajority of patients with uveitis had ESR and/or CRP values within the normal limits and no association of ESR and/
or CRP with the specific cause of uveitis was observed. However, elevation of ESR ≥ 60 mm/h and/or CRP ≥ 60 mg/L was
mostly seen in patients with systemic immune-mediated diseases (8/59, 14% of all with immune-mediated diseases) or systemic
infectious causes (7/38, 18% of all infectious uveitis). Patients with ocular toxoplasmosis typically exhibited normal ESR and
CRP (9/11, 82%) while patients with endogenous endophthalmitis had elevated ESR and/or CRP in 6/7, 86%. Sarcoidosis-
associated uveitis showed predominantly elevated ESR (13/24, 54%; range 20–59 mm/h in 11/13, 85%). Human immunodefi-
ciency virus–positive patients had more often elevated ESR values when compared to the remainder of patients (9/11, 82% vs.
64/163, 39%, 18%, P = 0.009). The cause of uveitis was established in 19/20 (95%) of patients with ESR ≥ 60 mm/h and/or CRP
≥ 60 mg/L.
Conclusions The majority of patients with first attack of uveitis had ESR and CRP within the normal limits. Elevated levels of
ESR and CRP reflected systemic involvement and high levels of both values were associated with established uveitis cause.
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Introduction
Uveitis is an intraocular inflammation of multiple causes,
which may result in permanent visual loss [1–4].
Erythrocyte sedimentation rate (ESR) and C-reactive protein
(CRP), both non-specific markers of inflammation, are usual-
ly included in the initial diagnostic workup. However, the
clinical value of these parameters in the adult uveitis popula-
tion is not known. Earlier investigations showed that ESR and
CRP are within the normal range in a majority of patients with
anterior uveitis [5]. In contrast, a recent report on juvenile
idiopathic arthritis (JIA)-associated uveitis in a pediatric pop-
ulation showed that elevated ESR predicted the development
of uveitis in patients with JIA [6]. However, it remains debat-
able whether ESR and CRP have any diagnostic value in
evaluation of uveitis in adult patients having a first uveitis
attack of unexplained origin.
Herein, we investigate the values of ESR and CRP during
the first episode of active uveitis, determined within a short
period after the onset in adult patients and relate the results to
specific etiologic categories and clinical characteristics of
uveitis.
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Materials and methods
The Strengthening the Reporting of Observational studies in
Epidemiology (STROBE) guidelines were used to ensure the
reporting of this observational study and this study followed
the Tenets of the Declaration of Helsinki [7].
We conducted a retrospective cross-sectional study at the
ophthalmology department of the Erasmus Medical Center
(Rotterdam, the Netherlands). All medical records of patients
referred with new uveitis of unknown origin investigated be-
tween 2010 and 2017 were reviewed and 174 patients were
identified who fulfilled our inclusion criteria. The onset of
uveitis was defined as the first time active inflammation was
documented by an ophthalmologist. ESR had to be deter-
mined ≤ 2 weeks and CRP values ≤ 1 week after the onset
uveitis (as ESR normalizes within weeks and CRP levels
within 7 days after resolution of tissue injury) [8]. Exclusion
criteria included age less than 18 years and patients with first
mild anterior uveitis episode as these patients do not undergo
diagnostic screening according to our guidelines. The ESR
and CRP values were arbitrarily stratified to three subgroups
(normal ESR < 20 mm/h, elevated ESR between 20 and
60 mm/h, highly elevated ESR ≥ 60 mm/h and normal CRP
< 10 mg/L (as defined in our laboratory), elevated CRP be-
tween 10 and 60 mg/L and highly elevated CRP ≥ 60 mg/L).
The following data were extracted from patients’ records:
age, gender, localization of uveitis, laterality, and human im-
munodeficiency virus (HIV) status. All immunosuppressive
medications as well as co-morbidities were registered.
Definitive anatomical classification was determined according
to the Standardization of Uveitis Nomenclature (SUN)
Working Group, by reviewing the whole follow-up period [9].
The cause of uveitis was determined after the diagnostic
examinations were completed. The diagnosis of definitive oc-
ular sarcoidosis was given to patients that had histologically
proven evidence and in all other cases; the criteria from the
International Workshop on Ocular Sarcoidosis (IWOS) were
used [10]. For the diagnosis of tuberculosis (TB)-associated
uveitis, a positive culture for mycobacteria in any fluid/tissue
sample was needed. Patients with a positive tuberculin skin
test (Mantoux test) or interferon gamma release assay (IGRA)
test with otherwise unexplained uveitis and no other indica-
tions of active tuberculosis were labeled as of unknown origin.
All other specific diagnoses were performed according to cur-
rent diagnostic criteria [10–16].
All statistical analyses were performed using SPSS soft-
ware (version 22.0, Chicago, IL, USA) and a P value of <
0.05 was considered statistically significant. Specific groups
were categorized as mentioned above and compared with each
other according to gender, anatomical localization of uveitis,
age, and etiology. Continuous variables were described by
mean and range, categorical variables with proportions, and
compared using the Mann-Whitney U test. Categorical
variables were compared using the chi-square test or Fisher’s
exact test.
Results
The results of ESR and CRP measurements are shown in
Table 1. Specific diagnoses in our cohort are depicted in the
Supplemental Table. A majority of patients was diagnosed
with associated non-infectious systemic diseases (59/174,
34%) and had non-anterior uveitis (141/174, 81%). Slight
female preponderance was observed (96/174, 55%).
Immunosuppressive medication (required for other causes
than uveitis) was used by 17/174, 10% patients. Patients suf-
fering from diabetes mellitus (DM) and patients using immu-
nosuppressive medication more often had elevated ESR
values (P = 0.018 for both, chi-square test), compared to the
remainder of patients. No significant differences in ESR and
CRP levels were found for gender, race, localization, or
laterality of uveitis (all P values > 0.05, chi-square test).
Furthermore, elevated values of ESR and/or CRP were not
significantly associated with any of the etiologic categories.
Concordance and discrepancies between ESR and CRP are
depicted in Table 2. A majority of patients had both ESR and
CRP values within the normal limits (91/174, 52%). Elevation
of only one of the parameters was seen in 50/174, 29%.
Elevated levels of both parameters were found in 33/174,
19% patients.
The median ESR and CRP of patients with uveitis of
established cause were higher than the median ESR and
CRP of patients with unknown uveitis (17.0 mm/h, range 1–
120 mm/h vs. 11.0 mm/h, range 1–140 mm/h for ESR and
3.4 mg/L, range 0.4–262.0 mg/L vs. 1.9 mg/L, range 0.3–
229.0 mg/L for CRP; P = 0.015 for both, Mann-Whitney U
test).
Out of 20 patients with either ESR ≥ 60 mm/h and/or CRP
≥ 60 mg/L, the cause of uveitis could be determined in 19/20.
Fifteen had either non-infectious systemic disease or systemic
infection, which was also a cause of uveitis (Table 3). The
remaining five patients had uveitis limited to the eye, but
had a concurrent systemic disorder, which explained their
highly elevated ESR and/or CRP but was not related to the
cause of uveitis (such as multiple myeloma in a patient with
infectious uveitis).
A majority of patients with infectious uveitis had ESR and
CRP values within the normal limits (17/38, 45%) or only
ESR ≥ 20 mm/h (14/38, 37%), see Table 2. Discrepant results
were more often noted in this group (17/38, 45% vs. 33/136,
24% P = 0.024, chi-square test). Patients with toxoplasmosis
exhibited normal ESR values in 9/11, 82%, and all had CRP
values within the normal limits. Patients with endogenous
endophthalmitis exhibited CRP ≥ 10 mg/L in 5/7, 71%.
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Patients with non-infectious uveitis commonly had ESR and
CRP values that were both within the normal limits (28/59, 47%;
Table 2). If elevated (N = 31), the parameters were most often
elevated simultaneously (15/31, 48%). Of the patients with HLA
B27-associated uveitis without systemic involvement, 2/8, 25%
exhibited CRP ≥ 10mg/L and 1/8, 13% had both ESR ≥ 20mm/
h and CRP ≥ 10 mg/L. Two patients had HLA B27-associated
uveitis with systemic involvement of which one had high eleva-
tion of CRP ≥ 60 mg/L and ESR ≥ 20 mm/h and the other ex-
hibited normal values. Sarcoidosis-associated uveitis showed a
predominantly elevated ESR (13/24, 54%; in the range between
20 and 59mm/h 11/13, 85%), while CRPwasmost often normal
(17/24, 71%). Systemic involvement in sarcoidosis patients (hilar
lymphadenopathy as seen on chest imaging) was present in 21/
24 (88%); however, in only 4/21 (19%) of these, treatment was
required.
The HIV was positive in 11/62, 18% tested patients. HIV-
positive patients had more often elevated ESR values when
compared to the remainder of patients (9/11, 82% vs. 64/163,
39%, P = 0.009, chi-square test). An infectious cause for uve-
itis was found in 9/11, 82% HIV-positive patients, out of
which 4/9, 44% had CMVretinitis and 4/9, 44% had syphilitic
uveitis. ESR ≥ 60 mm/h together with HIV positivity was
observed in 4/11, 36% (2 with CMV retinitis, one with syph-
ilitic uveitis, and one with sarcoidosis-associated uveitis).
Only one of the HIV-positive patients exhibited normal values
of both ESR and CRP; this patient was diagnosed with CMV
retinitis.
Discussion
In this retrospective, cross-sectional study, the majority of pa-
tients with a first active episode of uveitis of unknown origin
presented with normal ESR and CRP values. Moreover, no
significant relationship between the levels of these biomarkers
and specific causes of uveitis was found.
Earlier investigations of ESR and CRP in uveitis patients
also demonstrate normal values in a majority of patients with
anterior uveitis, but none of these previous studies defined the
time window in which ESR and CRP were determined in
relation to the onset of uveitis, while both biomarkers are
susceptible for changes within short periods [5, 8, 17].
Biomarkers like ESR and CRP are commonly assessed during
the diagnostic workup of new uveitis patients for potential
detection of infections or systemic immune-mediated dis-
ease-causing uveitis [1–4, 18–21]. Elevated levels of ESR
are due to a higher plasma protein levels (e.g., fibrinogen,
gamma globulins) and CRP is an acute phase protein released
after tissue injury caused by infections or other sources of
inflammation [8, 22].
Though a majority of patients with infectious uveitis in the
present study exhibited normal ESR and CRP values, in-
creased values were predominantly encountered in systemic
infections. The high levels of ESR and CRP were found in
patients with endogenous endophthalmitis, an ocular inflam-
mation that occurs concurrently with bacteremia. In contrast,
these inflammatory parameters were nearly always normal in
Table 1 Erythrocyte sedimentation rate and C-reactive protein of patients with a first episode of active uveitis of unknown cause
Total N = 174 ESRa CRPa
< 20 (N = 101) 20–59 (N = 57) ≥ 60 (N = 16) < 10 (N = 131) 10–59 (N = 33) ≥ 60 (N = 10)
Total 174 101/174 (58%) 57/174 (33%) 16/174 (9%) 131/174 (75%) 33/174 (19%) 10/174 (6%)
Diabetes mellitus 17/174 (10%) 5/17 (29%) 9/17 (53%) 3/17 (18%) 12/17 (71%) 5/17 (29%) 0
Immune suppressive medicationb 17/174 (10%) 5/17 (29%) 7/17 (41%) 5/17 (29%) 12/17 (71%) 2/17 (12%) 3/17 (18%)
Human immunodeficiency virus
positivityc
11/174 (6%) 2/11 (18%) 5/11 (45%) 4/11 (36%) 10/11 (91%) 0 1/11 (9%)
Anatomical localization
Anterior 33/174 (19%) 18/33 (55%) 10/33 (30%) 5/33 (15%) 23/33 (70%) 8/33 (24%) 2/33 (6%)
Intermediate 2/174 (1%) 1/2 (50%) 1 (50%) 0 2/2 (100%) 0 0
Posterior 45/174 (26%) 32/45 (71%) 12/45 (27%) 1/45 (2%) 37/45 (82%) 8/45(18%) 0
Panuveitis 86/174 (49%) 48/86 (56%) 30/86 (35%) 8/86 (9%) 65/86 (76%) 15/86(17%) 6/86 (7%)
Scleritis 8/174 (5%) 2/8 (25%) 4/8 (50%) 2/8 (25%) 4/8 (50%) 2/8 (25%) 2/8 (25%)
Non-infectious systemic disease 59/174 (34%) 33/59 (56%) 20/59 (34%) 6/59 (10%) 39/59 (66%) 14/59 (24%) 6/59 (10%)
Infectious uveitis 38/174 (22%) 20/38 (53%) 11/38 (29%) 7/38 (18%) 31/38 (82%) 4/38 (11%) 3/38 (8%)
Established clinical entity 24/174 (14%) 14/24 (58%) 8/24 (33%) 2/24 (8%) 17/24 (71%) 7/24 (29%) 0
Unknown 53/174 (30%) 34/53 (64%) 18/53 (34%) 1/53 (2%) 44/53 (83%) 8/53 (15%) 1/53 (2%)
ESR erythrocyte sedimentation rate, CRP C-reactive protein
a ESR had to be determined < 2 weeks of onset, CRP within < 1 week of onset
b Indicated for other causes than uveitis
c HIV was tested in 62 patients, out of which 11/62 (18%) were found positive
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patients with ocular toxoplasmosis, an intracellular parasite.
Reactivation of these dormant parasites within the eye is not
being accompanied by any systemic activity.
In HIV patients, the common hyperimmunoglobulinemia
causes elevation of ESR (rather than a direct infectious trigger
causing release of fibrinogen). In our series, highly elevated
ESR was often seen in HIV-positive patients, and therefore, it
might be therefore worthwhile to determine HIV status in
patients with uveitis of unknown origin and unexplained high
ESR [23]. Patients using immunosuppressive medications and
those suffering from DM had more often elevated ESR values
and the yield of these tests is therefore lower in these patients.
Elevated levels of ESR and CRP are common in systemic
sarcoidosis patients, specifically in sarcoidosis-associated ar-
thritis and erythema nodosum compared to other clinical pre-
sentations [24, 25]. Half of the patients with ocular sarcoido-
sis, however, had both normal ESR and CRP, which might
reflect mild (or lack of) systemic involvement at the moment
of onset of first uveitis attack [26]. This is also illustrated in the
current series, where the majority of patients had very mild
extraocular involvement which might also explain their pre-
dominantly normal ESR and CRP values.
In this study, follow-up measurements of ESR and/or CRP
were not available, and consequently, we do not have infor-
mation about the highest levels of ESR and CRP reached in
individual patients. Including the highest levels of ESR and
CRP could possibly expose some associations, which were
not found in the present study. In addition, the changes of
ESR and/or CRP might change in individual patients and
might be associated with impeding uveitis activity. However,
our main goal was to determine the diagnostic value of these
parameters during the first stage of uveitis after presentation.
Data on body mass index, which can influence the ESR and
CRP values, were not available in our patients [27].
In conclusion, our study reflects that presence of uveitis
alone is not sufficient to cause elevation of ESR and/or CRP
as a majority of patients with a first uveitis episode had ESR
and CRP values within the normal limits. In patients with
highly elevated ESR and/or CRP, the presence of a systemic
disease is very likely, and in consequence, the cause of uveitis
is being established in a vast majority of cases.
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